Kolexia
Helissey Carole
Oncologie médicale
Hopital Instruction des Armees Begin
Saint-Mandé, France
200 Activités
1.1 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs prostatiques résistantes à la castration Tumeurs du poumon Métastase tumorale Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes COVID-19 Cystite

Industries

Janssen
92 collaboration(s)
Dernière en 2023
AstraZeneca
18 collaboration(s)
Dernière en 2023
Bayer
17 collaboration(s)
Dernière en 2023
A+A
12 collaboration(s)
Dernière en 2023

Dernières activités

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer: A Phase 2, Randomized, Open-Label, Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
Essai Clinique (MacroGenics)   18 mars 2024
Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach.
Age and ageing   14 février 2024
Effects of preconditioning with TNFα and IFNγ in angiogenic potential of mesenchymal stromal cell-derived extracellular vesicles.
Frontiers in cell and developmental biology   21 décembre 2023
QUALIOR: Study Evaluating the Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program, for Metastatic Cancer Patients Receiving Oral Targeted Therapy: The UNICANCER SdS 01 QUALIOR Study
Essai Clinique (Unicancer)   07 novembre 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 novembre 2023
516MO Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, combined with osimertinib, as first-line therapy or after progression on osimertinib in non-small cell lung cancer (NSCLC)
Abstract Book of the ESMO Asia Congress 2023, 1-3 December 2023   01 novembre 2023
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
European urology oncology   26 octobre 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA oncology   26 octobre 2023
GIG-T: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Essai Clinique (Gustave-Roussy)   18 octobre 2023
2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023